tailieunhanh - Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease defined using a number of wellestablished molecular subsets. Application of non-negative matrix factorization (NMF) to whole exome sequence data has previously been used to identify six distinct molecular clusters in DLBCL with potential clinical relevance. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN